Sapna Syngal MD MPH
Director of Research, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute -- Co-Leader, Cancer Risk, Prevention, and Early Detection Program, Dana-Farber/Harvard Cancer Center -- Professor of Medicine, Harvard Medical School,
Join to View Full Profile
75 Francis StBrigham and Womens Hospital Division of GastroenterologBoston, MA 02115
Phone+1 617-632-5532
Fax+1 617-632-4088
Dr. Syngal is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Gastroenterology, 1993 - 1996
Harvard School of Public HealthMPH, Epidemiology, Biostatistics, 1993 - 1996- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
McGill University Faculty of MedicineClass of 1990
Certifications & Licensure
MA State Medical License 1992 - 2027
Awards, Honors, & Recognition
- Association of American Physicians 2018-2019
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2017
Clinical Trials
- Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) Start of enrollment: 2013 Oct 01
- The Cancer of the Pancreas Screening-5 CAPS5)Study Start of enrollment: 2014 Jan 06
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer Start of enrollment: 2023 Apr 25
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Detecting and Preventing Fraudulent Participation in Qualitative Research: Content Analysis of Two Multisite Studies.Destiny Harden, Nicolette Rodriguez, Kristi Roybal, Tara Coffin, Gina Johnson
Journal of Medical Internet Research. 2026-07-03 - A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.Tia L Kauffman, Elizabeth K O'Donnell, Catherine R Marinac, Ana Babic, Kareem Adams
Cancer Epidemiology, Biomarkers & Prevention. 2026-07-01 - Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.Saeed Soleymanjahi, Nicolette Juliana Rodriguez, Young-Rock Hong, Sneha Saha, Juhan Lee
Journal of the National Comprehensive Cancer Network. 2026-06-23
Journal Articles
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
Press Mentions
It’s in the BloodAugust 9th, 2024- FDA Approves New Blood Test to Screen for Colon Cancer That Should Be Covered by Insurance: ‘It’s Going to Have a Huge Impact’July 29th, 2024
- FDA Approves Blood Test Method for Colon Cancer ScreeningJuly 29th, 2024
Grant Support
- Design of a Scalable and Sustainable PREMMplus Patient-Facing App and Implementation in Three Healthcare SettingsDANA-FARBER CANCER INST2024–2029
- Great Lakes New England Clinical Validation CenterUNIVERSITY OF TX MD ANDERSON CAN CTR2000–2027
- Development and validation of clinical prediction models for the use and interpretation of multigene hereditary cancer risk assessmentDANA-FARBER CANCER INST2008–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
